Update on Capital Raising
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- June 2018 Quarterly Operational Update and App4C
- Achievement of Major Milestone - In vivo Cre Delivery
- Successful In-vivo Results Peptide Vaccine T-Cell Expansion
- CEO Update
- March 2018 Operational Update and Cashflow
Later from PYC Therapeutics
- Suspension from Official Quotation
- Phylogica Recapitalisation
- Reinstatement to Official Quotation
- R&D Tax Incentive Refund
- Fourfold Delivery Improvement in a New Lead Candidate
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics